Literature DB >> 17259448

Differential modulation of sodium- and chloride-dependent opioid peptide transport system by small nonopioid peptides and free amino acids.

Seiji Miyauchi1, Elangovan Gopal, Santosh V Thakkar, Satoshi Ichikawa, Puttur D Prasad, Vadivel Ganapathy.   

Abstract

We recently identified a novel opioid peptide transport system in the retinal pigment epithelium that transports opioid peptides by a Na+/Cl--dependent process. Here we describe a similar transport system expressed in SK-N-SH cells (a human neuronal cell line) and show for the first time that the activity of the transport system is modulated differentially by lysine and small nonopioid peptides. The transport process in SK-N-SH cells, monitored with deltorphin II as the substrate, is Na+/Cl--dependent and interacts with several opioid peptides, consisting of 5 to 13 amino acids. The activity of this transport system is markedly stimulated by specific dipeptides and tripeptides, with significant stimulation observable at low micromolar concentrations. The ion dependence, Na+/Cl--activation kinetics, and opioid peptide selectivity of the transport system, however, remain unchanged. The stimulation by the modulatory peptides is associated with an increase in maximal velocity with no change in substrate affinity of the system. Amino acids have no or little effect on the transport system, with the exception of lysine. This cationic amino acid inhibits the transport system, with significant inhibition occurring at physiologic concentrations of the amino acid. The inhibitory effect is primarily associated with a decrease in the maximal velocity of the transport system with little change in substrate affinity. Methyl and ethyl esters of lysine retain the inhibitory potency, but most other structural analogs have no effect. The differential modulation of the transport system by lysine and specific small peptides has important implications in the biology and pharmacology of opioid peptides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259448     DOI: 10.1124/jpet.106.116806

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Identification of a novel sodium-coupled oligopeptide transporter (SOPT2) in mouse and human retinal pigment epithelial cells.

Authors:  Paresh P Chothe; Santoshanand V Thakkar; Jaya P Gnana-Prakasam; Sudha Ananth; David R Hinton; Ram Kannan; Sylvia B Smith; Pamela M Martin; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

2.  Transport of the synthetic opioid peptide DADLE ([D-Ala2,D-Leu5]-enkephalin) in neuronal cells.

Authors:  Sudha Ananth; Santoshanand V Thakkar; Jaya P Gnana-Prakasam; Pamela M Martin; Preethi S Ganapathy; Sylvia B Smith; Vadivel Ganapathy
Journal:  J Pharm Sci       Date:  2011-09-08       Impact factor: 3.534

3.  Transport of hepcidin, an iron-regulatory peptide hormone, into retinal pigment epithelial cells via oligopeptide transporters and its relevance to iron homeostasis.

Authors:  Paresh P Chothe; Jaya P Gnana-Prakasam; Sudha Ananth; Pamela M Martin; Ram Kannan; David R Hinton; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  2011-01-08       Impact factor: 3.575

4.  Antiapoptotic properties of α-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells.

Authors:  Parameswaran G Sreekumar; Paresh Chothe; Krishna K Sharma; Rinku Baid; Uday Kompella; Christine Spee; Nandini Kannan; Christina Manh; Stephen J Ryan; Vadivel Ganapathy; Ram Kannan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-17       Impact factor: 4.799

5.  Functional identification of a novel transport system for endogenous and synthetic opioid peptides in the rabbit conjunctival epithelial cell line CJVE.

Authors:  Sudha Ananth; Senthil Karunakaran; Pamela M Martin; Chandrasekharam N Nagineni; John J Hooks; Sylvia B Smith; Puttur D Prasad; Vadivel Ganapathy
Journal:  Pharm Res       Date:  2008-09-10       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.